Respiratory failure & ventilation

Association between controlled mechanical ventilation and systemic inflammation in acute hypoxemic respiratory failure: an observational cohort study

Crit CarePublished Prospective observational cohort study

Authors' conclusion

In patients with acute hypoxemic respiratory failure initially breathing spontaneously, transition to CMV was associated with reduced IL-6 levels and improved ventilatory homogeneity over 24 h.

Study context

Population
ICU patients with acute hypoxemic respiratory failure initially breathing spontaneously
Participants
40 patients
Exposure
Transition to controlled mechanical ventilation (CMV) vs continued spontaneous breathing
  • CMVn = 28
  • SBn = 12reference
Outcome
IL-6 levels, CMV group, baseline vs 24 h
Follow-up
24 h
Methodological detailsGroup allocation based on clinical decisions
  • Group allocation based on clinical decisions

Main finding

As reported in the abstract

IL-6 baseline (CMV), mean ± SD, pg/mL
305 ± 938
IL-6 at 24 h (CMV), mean ± SD, pg/mL
27 ± 58
Change over time, P
p = 0.0195

Observational data: associations, not effects.

Further findings

Oxygenation (PaO2/FiO2), CMV group · 24 h

PaO2/FiO2 baseline to 24 h (CMV)
140 ± 51 to 199 ± 67
P
P = 0.0004
SB: no significant changes in gas exchange

Electrical impedance tomography (EIT) ventilation distribution · 24 h

CMV: increased end-expiratory lung impedance, decreased global inhomogeneity, dorsal shift of center of ventilation
SB: no significant changes in EIT-derived parameters

Respiratory rate and heart rate, CMV group

Decreased significantly over time

Original publication

Association between controlled mechanical ventilation and systemic inflammation in acute hypoxemic respiratory failure: an observational cohort study. Crit Care. Published 11 November 2025. doi:10.1186/s13054-025-05727-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.